The American College of Surgeons Cancer Programs developed the Cancer Surgery Standards Program, a new program that aims to improve the quality of surgical care provided to cancer patients by implementing standards for cancer surgery and standardizing the way operative data are documented and communicated.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
